122 related articles for article (PubMed ID: 26350793)
1. Quantitative Analysis of Formaldehyde-induced Fluorescence in Paraffin-embedded Specimens of Malignant Melanomas and Other Melanocytic Lesions.
Hara H; Naito M; Harada T; Tsuboi I; Terui T; Aizawa S
Acta Derm Venereol; 2016 Mar; 96(3):309-13. PubMed ID: 26350793
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic potential of fluorescence of formalin-fixed paraffin-embedded malignant melanoma and pigmented skin lesions: quantitative study of fluorescence intensity using fluorescence microscope and digital imaging.
Chwirot BW; Sypniewska N; Swiatlak J
Melanoma Res; 2001 Dec; 11(6):569-76. PubMed ID: 11725203
[TBL] [Abstract][Full Text] [Related]
3. Quantitative measurements of formalin-induced fluorescence for differential diagnostics of melanomas and lesions of human skin.
Sztramska A; Piwiński M; Chwirot BW
Melanoma Res; 2010 Oct; 20(5):408-16. PubMed ID: 20661163
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of fluorescence in malignant melanoma and nevocellular nevus using a fluorescence microscope and formalin-fixed specimens.
Shukuwa T; Nonaka S; Yoshida H
J Dermatol; 1990 Sep; 17(9):538-44. PubMed ID: 2277143
[TBL] [Abstract][Full Text] [Related]
5. Melan A/MART-1 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distribution.
Hofbauer GF; Kamarashev J; Geertsen R; Böni R; Dummer R
Melanoma Res; 1998 Aug; 8(4):337-43. PubMed ID: 9764809
[TBL] [Abstract][Full Text] [Related]
6. Will PAXgene substitute formalin? A morphological and molecular comparative study using a new fixative system.
Belloni B; Lambertini C; Nuciforo P; Phillips J; Bruening E; Wong S; Dummer R
J Clin Pathol; 2013 Feb; 66(2):124-35. PubMed ID: 23125305
[TBL] [Abstract][Full Text] [Related]
7. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic role of galectin 3 expression in cutaneous melanoma.
Abdou AG; Hammam MA; Farargy SE; Farag AG; El Shafey EN; Farouk S; Elnaidany NF
Am J Dermatopathol; 2010 Dec; 32(8):809-14. PubMed ID: 20885286
[TBL] [Abstract][Full Text] [Related]
9. Differential Clinicopathological Features in Spontaneous Regression of Melanomas and Melanocytic Naevi.
Martín JM; Pinazo I; Jordá E; Monteagudo C
Acta Derm Venereol; 2017 Jun; 97(6):692-697. PubMed ID: 28224168
[TBL] [Abstract][Full Text] [Related]
10. [Fluorescence histochemical and microfluorometrical investigations of pigmentary tumors of the skin (author's transl)].
Paul E; Hartwig HG; Möller W; Illig L
Arch Dermatol Res (1975); 1975 Sep; 253(2):125-44. PubMed ID: 1190835
[TBL] [Abstract][Full Text] [Related]
11. Application of fluorescence in situ hybridization as a diagnostic tool in melanocytic lesions, using paraffin wax-embedded tissues and imprint-cytology specimens.
Abásolo A; Vargas MT; Ríos-Martín JJ; Trigo I; Arjona A; González-Cámpora R
Clin Exp Dermatol; 2012 Dec; 37(8):838-43. PubMed ID: 22731835
[TBL] [Abstract][Full Text] [Related]
12. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma].
Pluot M; Joundi A; Grosshans E
Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of epidermal growth factor receptor in melanocytic tumours demonstrated by immunohistochemistry and mRNA in situ hybridization.
Sparrow LE; Heenan PJ
Australas J Dermatol; 1999 Feb; 40(1):19-24. PubMed ID: 10098284
[TBL] [Abstract][Full Text] [Related]
14. Molecular classification of melanomas and nevi using gene expression microarray signatures and formalin-fixed and paraffin-embedded tissue.
Koh SS; Opel ML; Wei JP; Yau K; Shah R; Gorre ME; Whitman E; Shitabata PK; Tao Y; Cochran AJ; Abrishami P; Binder SW
Mod Pathol; 2009 Apr; 22(4):538-46. PubMed ID: 19270649
[TBL] [Abstract][Full Text] [Related]
15. [Nevus associated malignant melanomas--diagnostic validation and prognosis].
Stadler R; Garbe C
Hautarzt; 1991 Jul; 42(7):424-9. PubMed ID: 1938395
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence of melanoma cells. A useful diagnostic tool.
Inoshita T; Youngberg GA
Am J Clin Pathol; 1982 Sep; 78(3):311-5. PubMed ID: 7113967
[TBL] [Abstract][Full Text] [Related]
17. Proliferative activity in Spitz's naevi compared with other melanocytic skin lesions.
Hofmann-Wellenhof R; Rieger E; Smolle J; Kerl H
Melanoma Res; 1993 Oct; 3(5):313-7. PubMed ID: 7904841
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 (COX-2): first immunohistochemical marker distinguishing early cutaneous melanomas from benign melanocytic skin tumours.
Chwirot BW; Kuźbicki Ł
Melanoma Res; 2007 Jun; 17(3):139-45. PubMed ID: 17505259
[TBL] [Abstract][Full Text] [Related]
19. Formaldehyde-induced fluorescence in melanomas and other lesions. Diagnostic significance and mechanism of fluorescence.
Dalal BI; Slinger RP
Arch Pathol Lab Med; 1985 Jun; 109(6):551-4. PubMed ID: 3838885
[TBL] [Abstract][Full Text] [Related]
20. High-resolution MALDI-FT-ICR MS imaging for the analysis of metabolites from formalin-fixed, paraffin-embedded clinical tissue samples.
Buck A; Ly A; Balluff B; Sun N; Gorzolka K; Feuchtinger A; Janssen KP; Kuppen PJ; van de Velde CJ; Weirich G; Erlmeier F; Langer R; Aubele M; Zitzelsberger H; Aichler M; Walch A
J Pathol; 2015 Sep; 237(1):123-32. PubMed ID: 25965788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
